Viking Therapeutics Inc (VKTX)
42.25
+0.76
(+1.83%)
USD |
NASDAQ |
Dec 20, 16:00
43.20
+0.95
(+2.25%)
After-Hours: 04:07
Viking Therapeutics Free Cash Flow: -74.25M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen Inc | 6.283B |
| Eli Lilly and Co | -2.275B |
| Pfizer Inc | 8.227B |
| Merck & Co Inc | 14.84B |
| Vertex Pharmaceuticals Inc | -1.352B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -21.96M |
| Cash from Investing (Quarterly) | 25.90M |
| Cash from Financing (Quarterly) | 2.522M |
| Free Cash Flow Per Share (Quarterly) | -0.198 |
| Free Cash Flow Yield | -1.65% |